Avant Bio
Venture capitalNew York · Seed–Growth · 5 people tracked
Investment thesis
AVANT BIO invests in companies at the convergence of advanced technologies and biology, focusing on therapeutic enabling technologies and healthtech solutions that address unmet needs in modern drug development. The firm recognizes that innovative companies combining cutting-edge technologies with deeper biological understanding create exceptional opportunities for investment. By leveraging insider access and deep expertise, AVANT BIO identifies high-potential companies with stability and promising returns while providing strategic guidance and connections to maximize value creation.
Source: firm website, verified Jul 21, 2026.
Team · 5 people
from the firm's websiteWhat they invest in
from 1 of 6 portfolio companiesHealthtech ×1Medical Devices ×1
HQs:United States×3Canada×1
Investments · 6 tracked
founders shown can be your intro pathNomic Bio develops an immunoassay platform that enables drug discovery scientists to profile hundreds of proteins with higher throughput and lower cost than conventional methods. The company is initially targeting high-throughput screening groups at pharmaceutical and biotech firms.
HealthtechMedical DevicesMontreal, CA
Board seats · per SEC filings · 4
what is this? ⓘ$3M raise · filed Dec 2025 · via Daniella T.C. Kranjac
$12M raise · filed Jul 2024 · via Daniella Kranjac
Raise · filed May 2024 · via Daniella Kranjac
$41M raise · filed Jun 2023 · via Daniella Kranjac
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Avant Bio invest at?
- Avant Bio invests at the Seed, Series A, Series B, Growth stages.
- What sectors does Avant Bio focus on?
- Avant Bio focuses on AI & Machine Learning, Biotech, Deep Tech, Healthtech.
- Where is Avant Bio located?
- Avant Bio is headquartered in New York, US.
- Does Avant Bio lead rounds?
- Yes, Avant Bio leads investment rounds.
Similar investors
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.